Wei Dong Jiang
Founder en SHANGHAI HENLIUS BIOTECH, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Wei Dong Jiang is the founder of two companies, Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech, Inc., both founded in 2009.
He held the title of Chief Scientific Officer & Vice President at Henlius Biopharmaceuticals, Inc. and Chief Scientific Officer & Senior Vice President at Shanghai Henlius Biotech, Inc. Dr. Jiang has a doctorate degree from the University of Giessen and an undergraduate degree from Zhejiang University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2023 | 720 955 ( 0.44% ) | 1 M $ | 31/03/2024 |
Cargos activos de Wei Dong Jiang
| Empresas | Cargo | Inicio |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Founder | 01/12/2009 |
Antiguos cargos conocidos de Wei Dong Jiang.
| Empresas | Cargo | Fin |
|---|---|---|
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Founder | - |
Formación de Wei Dong Jiang.
| University of Giessen | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Wei Dong Jiang
